BSE filing, NSE: MEDICAMEQ. Summary written from the filing by ALFA Finder's alert engine.
Medicamen Biotech Ltd: key numbers
- Share price
- ₹258.20
- Market cap
- ₹363.1 Cr
- Revenue (annual)
- ₹197.8 Cr
- Net profit (annual)
- ₹9.64 Cr
- P/E (TTM)
- 33.5×Sector 42.0×
- Promoter holding
- 42.57%+2.11% QoQ
- FII holding
- 4.35%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Medicamen Biotech Ltd
All →Medicamen Biotech Board Meeting Date
Medicamen Biotech will meet on 13 Nov 2026 to consider half-yearly results for September 2026. Trading window stays closed from 01 Oct to 16 Nov 2026.
Medicamen Biotech Preferential Issue
Medicamen Biotech allotted 50 lakh equity shares at ₹530 per share under its preferential issue. The allotment raises ₹265 Crore in fresh equity capital.
- Value
- ₹265.0 Cr
Medicamen Biotech Preferential Issue
Medicamen Biotech allotted 5,00,000 equity shares at ₹530 each in a preferential issue to one investor. The allotment raised ₹26.5 Crore, taking paid-up capital to ₹14.06 Crore.
- Value
- ₹26.50 Cr
Medicamen Biotech Convertible Warrants
Medicamen Biotech allotted 5,00,000 equity shares to Shivalik Rasayan Ltd via warrant conversion at ₹530 each, raising ₹26.5 Crore. Paid-up capital rises to ₹14.06 Crore.
- Value
- ₹26.50 Cr
Medicamen Biotech Other Announcement
The company submitted its quarterly shareholding pattern under Regulation 31(1)(b) for the quarter ended 30 September 2026.
Medicamen Biotech Other Announcement
Medicamen Biotech Limited's Director Sanjay Bansal sold 32,813 shares on the open market, as per a regulatory filing.
- Value
- ₹1.05 Cr
Other board meeting date announcements
All →Cerebra Integrated Technologies Board Meeting Date
Cerebra Integrated Technologies Limited intimated a board meeting on 12 Nov 2026 to consider unaudited standalone and consolidated quarterly results for September 2026. Trading window closes 16 Nov 2026.
RSD Finance Board Meeting Date
RSD Finance Ltd intimated a board meeting on 13 Nov 2026 to consider unaudited standalone and consolidated half-yearly results for September 2026. Trading window closes 15 Nov 2026.
Xtglobal Infotech Board Meeting Date
XTGLOBAL INFOTECH Limited intimated a board meeting on 13 Nov 2026 to consider unaudited standalone and consolidated half-yearly results for September 2026, plus ESOP and other business. Trading window closes 15 Nov 2026.
India Nippon Electricals Board Meeting Date
India Nippon Electricals Limited intimated a board meeting on 12 Nov 2026 to consider unaudited standalone half-yearly results for September 2026. Trading window is closed from 01 Oct 2026 until 48 hours after results.
Seemax Resources Board Meeting Date
Seemax Resources Limited intimated a board meeting on 14 Nov 2026 to consider unaudited standalone half-yearly financial results for September 2026. Trading window stays closed until 16 Nov 2026.
Star Delta Transformers Board Meeting Date
Star Delta Transformers schedules a board meeting on 13 November 2026 to consider unaudited standalone half-year results. Trading window closes from 1 October until results are declared.